Facebook
Twitter
LinkedIn
Forward
SHEA Spring 2019 Full Conference Recordings
SHEA’s overall goal for SHEA Spring 2019 is for participants to gain valuable knowledge about the latest research and science in healthcare epidemiology, practical skills and strategies to implement this knowledge, and ongoing connections with other professionals in the field of healthcare epidemiology and infection prevention.
*You will no longer be able to claim CME credits for this course when accreditation closes - 12/31/19
Sessions
Wednesday 4/24:
- Opening Plenary: Show Me How to Do That! Partners Outside the Infection Prevention Department
- Interesting Cases in Infection Prevention
- Antibiotic Stewardship Globe Trotters
- How CORHA is Addressing the Climate of Secrecy
- Won't You Be My Mentor?
- Where Are We Now?
- Going Where the Action Is: Infection Prevention Concerns in Ambulatory Settings
Thursday 4/25:
- Culture - Why it Matters
- Putting the Fun in Unfunded: Regulatory Requirements in post-Acute & Long-Term Care Settings
- Worries with Water
- Plenary: Partnering with Non-Profits to Improve Antibiotic Stewardship: The Pew Charitable Trusts
- Sepsis... A Seat at the Table
- What's New in SSI Prevention?
- Tackling the Fecal Patina: It Takes More than a Mop
Friday 4/26:
- Ebola 5 Years Later: Applying Lessons Learned from the Biocontainment Units to the Ward
- Qualitative and Mixed-Methods Research Strategies with a Practical Twist for Infection Prevention
- HAI in Pediatrics 2019
- Joint SHEA/APIC Session - SSI Prevention Strategies: IP in the OR
- Pro/Con: Is it Time to Change the Dress Code? Contact Precautions for MRSA and VRE in Pediatrics
- Pro/Con: Diagnostic Stewardship for C. diff - Are We Building Our Own Latrine?
- Closing Plenary: The Importance of Diversity in Our partnerships
Target Audience
This conference is designed for physicians, infection preventionists, healthcare epidemiologists, infectious disease specialists, microbiologists, nurses, pharmacists, and other healthcare professionals interested in healthcare epidemiology, infection prevention, surveillance, research methods, patient safety, environmental issues and quality improvement.
Learning Objectives
At the conclusion of the course, learners should be able to:
- Review and critique new scientific evidence related to epidemiologic methods and prevention of healthcare-associated infections (HAIs).
- Identify evolving public policy developments and their impact on HAI prevention.
- Compare and contrast differing approaches to controversial aspects of HAI prevention.
- Translate best methods in healthcare epidemiology, antibiotic stewardship, surveillance, prevention, and research into practice.
- Apply and evaluate appropriate antibiotic stewardship practices in acute and non-acute healthcare settings.
- Discuss current best practices in HAI prevention in individual clinical settings including Pediatrics and Long-term Care.
- Apply practical strategies to effectively communicate healthcare epidemiology, HAI prevention and antibiotic stewardship knowledge and practices to patients, healthcare personnel and policy makers.
PLANNING COMMITTEE & SPEAKERS
Deverick Anderson, MD, MPH | Robin Jump, MD, PhD Contracted Research/Principal Investigator: Pfizer, Accelerate |
Gonzalo Bearman, MD, MPH | Marion Kainer, MD, MPH Disclosed no relevant financial relationships |
| Barbara Braun, PhD Disclosed no relevant financial relationships | Sarah Krein, PhD, RN Disclosed no relevant financial relationships |
| Michael Calderwood, MD, MPH Disclosed no relevant financial relationships | Kristi Kuper, PharmD Disclosed no relevant financial relationships |
| Dennis Drapiza, MPH, BSN, RN, CIC Disclosed no relevant financial relationships | Matthew Linam, MD, MS Disclosed no relevant financial relationships |
| Chair Judy Guzman-Cottrill, DO Disclosed no relevant financial relationships | Priya Nori, MD Disclosed no relevant financial relationships |
| Sarah Haessler, MD Disclosed no relevant financial relationships | Vice-Chair Tom Sandora, MD, MPH Disclosed no relevant financial relationships |
| Lauri Hicks DO Disclosed no relevant financial relationships | Marin Schweizer, PhD Disclosed no relevant financial relationships |
| Joost Hopman, MD Disclosed no relevant financial relationships | Geetika Sood, MD, ScM Disclosed no relevant financial relationships |
| Jesse Jacob, MD Disclosed no relevant financial relationships | Nimalie Stone, MD, MS Disclosed no relevant financial relationships |
| Helen Jacoby, MD Disclosed no relevant financial relationships | Kavita Trivedi, MD Disclosed no relevant financial relationships |
STAFF
Laure Herzog
Disclosed no relevant financial relationships
Jessica Johnson
Disclosed no relevant financial relationships
Jade Belcher
Disclosed no relevant financial relationships
SPEAKERS
Allison Aubrey, MS | David Hyun, MD Disclosed no relevant financial relationships | Trish Perl, MD, MSc Disclosed no relevant financial relationships |
| Hilary Babcock, MD, MPH Disclosed no relevant financial relationships | Sameer Kadri, MD Disclosed no relevant financial relationships | Joseph Perz, DrPH, MA Disclosed no relevant financial relationships |
| Michael Bell, MD Disclosed no relevant financial relationships | Anju Kagal, MD Disclosed no relevant financial relationships | Chanu Rhee, MD, MPH Disclosed no relevant financial relationships |
| Kimberly Blumenthal, MD,MSc Property Rights/Ownership: Copyright for beta-lactam allergy decision support tool | Keith Kaye, MD, MPH Disclosed no relevant financial relationships | William Rutala, MPH, PhD Consulting Fee: PDI, ASP Honoraria: PDI, ASP, 3M Contracted Research/Advisory Board:Kinnos |
| Kristina Bryant, MD Disclosed no relevant financial relationships | Dale Krageschmidt, PhD Disclosed no relevant financial relationships | Nasia Safdar, MD, PhD Disclosed no relevant financial relationships |
| Philip Carling, MD Disclosed no relevant financial relationships | Kerry LaPlante, PharmD Contracted Research/Investigator: Merck, Pfizer, Ocean Spray Cranberries, Inc Contracted Research/Scientific Advisor: Nabriva Therapeutics US, Inc, Melinta Therapeutics, Inc, Tetraphase Pharmaceuticals, Paratek Pharmaceuticals | Luke Schulz, PharmD Speaker’s Bureau: Astellas, Melinta Contracted Research: Merck |
Vineet Chopra, MD, MSc | Grace Lee, MD, MPH Disclosed no relevant financial relationships | Nathan Shively, MD Disclosed no relevant financial relationships |
Susan Coffin, MD, MPH | Latania Logan, MD, MS Disclosed no relevant financial relationships | Rachel Smith, MD Disclosed no relevant financial relationships |
Laura Cooley, MD, MPHTMa | Monica Mahoney, PharmD Consulting Fee: Merck Contracted Research/Advisory Board: Melinta, Tetraphase, Cutis, Roche Diagnostics | Arjun Srinivasan, MD Disclosed no relevant financial relationships |
Elizabeth Dodds-Ashley,PharmD | Anurag Malani, MD Disclosed no relevant financial relationships | Thomas Talbot, MD, MPH Contracted Research (Spouse): Sanofi Pasteur, Medimmune, Sequiris |
Curtis Donskey, MD | Marc Meyer, BPharm Disclosed no relevant financial relationships | Pranita Tamma, MD Disclosed no relevant financial relationships |
Shira Doron, MD | Daniel Morgan, MD, MS Disclosed no relevant financial relationships | Valerie Vaughn, MD, MSc Disclosed no relevant financial relationships |
Frank Drews, PhD | Andrew Morris, MD, SM Disclosed no relevant financial relationships | Lindsay Visnovsky, PhD, MS Disclosed no relevant financial relationships |
| Erik Dubberke, MD, MSPH Consulting Fee: Valneva, Achogen, Pfizer, Rebiotix, Sanofi | David Nace, MD, MPH Disclosed no relevant financial relationships | Maroya Walters, MSc, PhD Disclosed no relevant financial relationships |
| Margret Dudeck, BS, MPH Disclosed no relevant financial relationships | Ann-Christine Nyquist, MD, MSPH Disclosed no relevant financial relationships | Deborah Yokoe, MD, MPH Disclosed no relevant financial relationships |
| Ghinwa Dumyati, MD Disclosed no relevant financial relationships | Rita Olans, DNP Disclosed no relevant financial relationships | Shanta Zimmer, MD Disclosed no relevant financial relationships |
| Jonathan Edwards, MStat Disclosed no relevant financial relationships | Michael Osterholm, MPH,PhD Disclosed no relevant financial relationships | Maureen Tierney, MD, MSc Disclosed no relevant financial relationships |
| Neil Fishman, MD Disclosed no relevant financial relationships | Belinda Ostrowsky, MD, MPH Disclosed no relevant financial relationships | Sarah Kogut, MPH, CIC Disclosed no relevant financial relationships |
| Kathleen Gase, MBA, MPH, CIC Disclosed no relevant financial relationships | Kaede Ota Sullivan, MD, MSc Disclosed no relevant financial relationships | Jane Greenko, RN, MPH Disclosed no relevant financial relationships |
| Ayse Gurses, PhD, MS, MPH Disclosed no relevant financial relationships | Tara Palmore, MD Disclosed no relevant financial relationships | Bryan Christensen, PhD Disclosed no relevant financial relationships |
| Karen Hoffmann, RN, MS Disclosed no relevant financial relationships | Priti Patel, MD Disclosed no relevant financial relationships |
ACCREDITATION STATEMENT
The Society for Healthcare Epidemiology of America is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credits Expiration: December 31, 2019
PHYSICIANS
The Society for Healthcare Epidemiology of America designates this enduring material for a maximum of 29.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INTERNATIONAL PHYSICIANS
The American Medical Association has determined that physicians not licensed in the United States who participate in this continuing medical education activity are eligible for AMA PRA Category 1 Credit(s)TM.
SUCCESSFUL COMPLETION STATEMENT
Participants are expected to claim only those hours spent in the educational activities approved for continuing education credit. Certificates are provided to registered attendees based upon completion of the evaluation.
CONTENT VALIDATION STATEMENT
The Society for Healthcare Epidemiology of America accepts the following content validation statements and expects all persons involved in its professional education activities to abide by these statements with regard to any recommendations for clinical care.
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contradictions in the care of patients; and/or all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
COMMERCIAL SUPPORTERS
The SHEA Spring 2019 Conference: Science Guiding Prevention, is supported in part by educational grants from the following companies:
- Merck & Co, Inc.
- Pfizer, Inc.
- Sage Products, now part of Stryker
- Johnson & Johnson, Medical Devices Companies
Available Credit
- 29.50 AMA PRA Category 1 Credit™The Society for Healthcare Epidemiology of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Accreditation Period
Price
Course Instructions:
You may select specific sessions for purchase by clicking individual checkboxes, or check the SHEA Spring 2019 Full Conference Recordings box to purchase the entire package. After making your selections click the blue "ENROLL" button above.
To claim CME credit:
CREDITS EXPIRATION: DECEMBER 31, 2019
Go through the session(s), take the session evaluation(s), take the OVERALL COURSE EVALUATION located at the bottom of the registration page, and then download or print your SHEA Spring 2019 Full Conference Recording certificate.